Guardian Pharmacy Services

GRDN

Market cap $1.71B

Guardian Pharmacy Services, Inc. (GRDN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services (NYSE: GRDN), one of the nation's leading long-term care (“LTC”) pharmacy services companies, is reiterating its previously announced 2025 guidance and providing its preliminary financial outlook for 2026. The Company expects to continue its low double-digit adjusted EBITDA growth trajectory in 2026, supported by the strength of its operating model and increased visibility into the year ahead, including anticipated drug pricing changes. The C.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today confirmed the company will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The company's leadership team will host investor meetings on Wednesday, January 14th, and present at 4:30 p.m. PT the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be accessible shortly after the event and will remain available for.

Guardian Pharmacy Services Inc. NYSE: GRDN, a small-cap healthcare company, made waves in Tuesday's session after reporting better-than-expected earnings that sent the stock surging on above-average volume.

Barely one year after its IPO, the company is doing a decent job finding its niche. This was strongly evidenced by its 20% revenue jump in the third quarter.

Guardian Pharmacy Services (GRDN) came out with quarterly earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to a loss of $2 per share a year ago.

Guardian Pharmacy Services, Inc. ( GRDN ) Q3 2025 Earnings Call November 10, 2025 4:30 PM EST Company Participants Ashley Stockton - Head of Investor Relations & Senior Director Fred Burke - CEO, President & Director David Morris - CFO, Executive VP & Director Conference Call Participants John Ransom - Raymond James & Associates, Inc., Research Division David MacDonald - Truist Securities, Inc., Research Division Raj Kumar - Stephens Inc., Research Division Presentation Operator Good day, everyone, and welcome to Guardian Pharmacy's Third Quarter Earnings Call. [Operator Instructions] I will now hand the call over to Ashley Stockton.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's leading long-term care ("LTC") pharmacy services companies, announced today its financial results for the third quarter ended September 30, 2025. The Company also raised its full-year revenue and Adjusted EBITDA guidance. Third Quarter Financial Results Revenue of $377.4 million, up 20% year-over-year. Residents served ended the quarter at approximately 204,000, up 13% year-over-year. Net Income (loss).

Guardian Pharmacy (GRDN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will participate in the Stephens Investment Conference in Nashville, TN, on Wednesday, November 19, 2025. The company will host investor meetings, and Fred Burke, Co-founder and Chief Executive Officer, will take part in a fireside chat at 11:00 a.m. CT (12:00 p.m. ET) the same day. A live audio webcast of the session will be available at https://investors.guardianpharmacy.com. A replay will be acces.